AmentoTech Doctreat Core Plugin up to 1.6.8 on WordPress doctreat_process_registration privileges management
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 8.4 | $0-$5k | 2.58+ |
Summary
A vulnerability was found in AmentoTech Doctreat Core Plugin up to 1.6.8 on WordPress and classified as critical. This affects the function doctreat_process_registration. Such manipulation leads to privileges management.
This vulnerability is documented as CVE-2025-6254. The attack can be executed remotely. There is not any exploit available.
Details
A vulnerability, which was classified as critical, has been found in AmentoTech Doctreat Core Plugin up to 1.6.8 on WordPress. Affected by this issue is the function doctreat_process_registration. The manipulation with an unknown input leads to a privileges management vulnerability. Using CWE to declare the problem leads to CWE-269. The product does not properly assign, modify, track, or check privileges for an actor, creating an unintended sphere of control for that actor. Impacted is confidentiality, integrity, and availability. CVE summarizes:
The Doctreat Core plugin for WordPress is vulnerable to Privilege Escalation in all versions up to, and including, 1.6.8. This is due to the doctreat_process_registration() function not properly restricting the roles that a user can register with. This makes it possible for unauthenticated attackers to register as an administrator user.
The weakness was released by Friderika Baranyai. The advisory is shared for download at wordfence.com. This vulnerability is handled as CVE-2025-6254 since 06/18/2025. The exploitation is known to be easy. The attack may be launched remotely. No form of authentication is required for exploitation. There are known technical details, but no exploit is available. The current price for an exploit might be approx. USD $0-$5k (estimation calculated on 06/10/2026). The MITRE ATT&CK project declares the attack technique as T1068.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the vulnerability database at EUVD (EUVD-2025-210104). VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Type
Vendor
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 8.5VulDB Meta Temp Score: 8.4
VulDB Base Score: 7.3
VulDB Temp Score: 7.1
VulDB Vector: 🔒
VulDB Reliability: 🔍
CNA Base Score: 9.8
CNA Vector (Wordfence): 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Privileges managementCWE: CWE-269 / CWE-266
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
06/18/2025 CVE reserved06/10/2026 Advisory disclosed
06/10/2026 VulDB entry created
06/10/2026 VulDB entry last update
Sources
Advisory: wordfence.comResearcher: Friderika Baranyai
Status: Not defined
CVE: CVE-2025-6254 (🔒)
GCVE (CVE): GCVE-0-2025-6254
GCVE (VulDB): GCVE-100-370136
EUVD: 🔒
Entry
Created: 06/10/2026 15:33Updated: 06/10/2026 16:18
Changes: 06/10/2026 15:33 (65), 06/10/2026 16:18 (1)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.